10x Genomics announces collaboration with Brigham & Women’s Hospital

10x Genomics (TXG) announced a collaboration with Brigham & Women’s Hospital to analyze peripheral blood samples from patients living with rheumatoid arthritis, systemic lupus erythematosus and giant cell arteritis to uncover immune signatures associated with disease activity, flare, remission and therapeutic response. As part of this effort, 10x and Brigham & Women’s Hospital also plan to build a framework for a future clinical report, defining how blood-based molecular features, such as immune activation patterns or markers of disease trajectory, could be translated into a clear, clinically relevant summary to support physicians as they evaluate disease activity and plan treatments for autoimmune disease.